Table 2 Adverse events
Adverse event | Number of patients reporting adverse events | Grade |
|---|---|---|
Blood and lymphatic system disorders | ||
Anemia | 3 | 1 |
Decreased WBC count | 1 | 1 |
Cardiac disorders | ||
Prolonged QTc | 6 | 1, 2 |
Coronary artery disease | 1 | 4 |
Syncope | 1 | 4 |
Endocrine disorders | ||
Hyperglycemia | 3 | 1 |
Gastrointestinal disorders | ||
Nausea | 2 | 1 |
Diarrhea | 1 | 1 |
Reflux | 1 | 1 |
General disorders | ||
Headache | 3 | 1 |
Hepatobiliary disorders | ||
Elevated total bilirubin | 5 | 1 |
Increased AST | 5 | 1 |
Increased ALT | 4 | 1 |
Increased amylase | 2 | 1 |
Increased lipase | 2 | 1 |
Metabolism and nutrition disorders | ||
Low inorganic phosphorus | 1 | 1 |
Vitamin D deficiency | 1 | 1 |
Nervous system disorders | ||
Dizziness | 1 | 1 |
Psychiatric disorders | ||
Anxiety | 1 | 1 |
Concentration impairment | 1 | 1 |
Reproductive system and breast disorders | ||
Erectile dysfunction | 1 | 1 |
Skin and subcutaneous tissue disorders | ||
Rash acneiform | 1 | 2 |
Alopecia | 1 | 1 |